GL1X · GenesisL1 explorer

Research workbench

Structure of human THR160-phospho CDK2/CYCLIN a complexed with a 2-arylamino-4-cyclohexylmethyl-5-nitroso-6-aminopyrimidine inhibitor

Analyse Structure of human THR160-phospho CDK2/CYCLIN a complexed with a… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1OGU
Type
protein
Length
1,078 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cell division protein kinase 2; Cyclin A2
EC
2.7.1.37
UniProt
P24941, P20248
Ligands
ST8
Pockets
13 · best druggability 0.81

Structure

x-ray diffraction · 4 distinct chains · 50% helix, 9% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACell division protein kinase 2 (EC 2.7.1.37)protein29735% helix, 16% strandP24941
BCyclin A2protein25369% helix, 0% strandP20248
CCell division protein kinase 2 (EC 2.7.1.37)protein27336% helix, 19% strandP24941
DCyclin A2protein25565% helix, 0% strandP20248

Ligands and binding sites

  • ST8 · 4-{[4-amino-6-(cyclohexylmethoxy)-5-nitrosopyrimidin-2-yl]amino}benzamide · ligand · 2 copies · chains A, C
  • SGM · Monothioglycerol · additive · 2 copies · chains B, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

13 pockets found on a 1 Å grid, 8 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11270.810.9823empty
21220.800.9825empty
39190.760.7990empty
42130.670.8526ST8
52400.660.8329ST8

Interfaces

5 interfaces between chains.

  • C–D · 1664 Ų buried · 23 hydrogen bonds · protein-protein
  • A–B · 1584 Ų buried · 28 hydrogen bonds · protein-protein
  • B–C · 575 Ų buried · 4 hydrogen bonds · protein-protein
  • A–D · 550 Ų buried · 6 hydrogen bonds · protein-protein
  • A–C · 115 Ų buried · 1 hydrogen bond · protein-protein

Modifications

Observed in the structure: 2 covalent, 2 modified (additive adduct, phosphorylation).

Compared structures

  • 1OGU · Structure of human THR160-phospho CDK2/CYCLIN a complexed with a… · the same entry in another collection · chain C against C, TM-score 1.00
  • P20248 · AlphaFold monomer V2.0 prediction for cyclin-A2 (P20248) · a predicted model of the same protein · chain B against A, TM-score 1.00
  • P24941 · AlphaFold monomer V2.0 prediction for cyclin-dependent kinase 2 (P24941) · a predicted model of the same protein · chain A against A, TM-score 0.91

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.